Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy, safety, and pharmacokinetics of etokimab (ANB020) in adults with moderate-to-severe atopic dermatitis completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Etokimab

Snippet

Sponsor: AnaptysBio, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24